Brain map of basal ganglia aids Parkinson’s therapy in mice
A large scientific collaboration has produced the most detailed map yet of the basal ganglia, a brain region linked to Parkinson’s disease, schizophrenia, and depression. Researchers profiled more than 25 million cells. The map is already informing more precise treatments in mouse models.
The basal ganglia are a cluster of deep brain structures central to movement and behavior. Disruptions in this region are associated with a wide range of disorders. Using data from more than 25 million cells, the researchers generated a detailed parts list of the cell types present and how they are arranged.
New cell type linked to schizophrenia
During the analysis, the scientists identified a previously unknown type of neuron that appears to play a role in schizophrenia. They also identified cell types linked to depression, bipolar disorder, and post-traumatic stress disorder. These findings provide potential targets for therapies that could intervene more selectively.
Greater precision in mapping the region means treatments can be more targeted. That matters because broad interventions in the basal ganglia can carry unwanted side effects.
Gene therapy works more selectively in mice
In mouse models of Parkinson’s disease, the researchers tested a gene therapy directed at a subset of basal ganglia cells. That targeted approach was as effective as a broader strategy, while also being safer. This represents an early proof of concept, and whether the same findings apply in humans is not yet known.
The results suggest a growing capacity to tailor brain treatments to specific cell types. Whether and when this will translate into new therapies for people remains to be seen.
Want to research this yourself?
Search for example:
- basal ganglia cell type atlas
- gene therapy Parkinson’s brain region
- single-cell neuronal profiling